Dr. Jeffrey R. Jay, M.D. »

Miragen Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-03-31 $23M 1.3M 17.51

More positions owned by Dr. Jeffrey R. Jay, M.D.

Neurogene (NGNE)
Alpine Immune Sciences (ALPN)
Urogen Pharma (URGN)
Abivax Sa Sponsored Ads (ABVX)
Evolus (EOLS)
Pliant Therapeutics (PLRX)
Apogee Therapeutics (APGE)
Aerovate Therapeutics (AVTE)
Miragen Therapeutics (VRDN)
Anaptysbio Inc Common (ANAB)
Esperion Therapeutics (ESPR)
Insmed Com Par $.01 (INSM)
Arcellx Common Stock (ACLX)
Xenon Pharmaceuticals (XENE)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Miragen Therapeutics

FMR
Paradigm Biocapital Advisors
State Street Corporation
VR Adviser
BlackRock
Perceptive Advisors
Deep Track Capital
Vanguard Group
Maverick Capital
Commodore Capital
Fairmount Funds Management
Alliancebernstein
Vivo Capital
Dr. Jeffrey R. Jay, M.D.
Nuveen Asset Management

View all funds holding Miragen Therapeutics